(Q44233372)

1 December 2017

title

High-risk elderly patients PROSPER from cholesterol-lowering therapy (English)

1 reference

1 December 2017

Rory Collins

1

1 reference

1 December 2017

Jane Armitage

series ordinal

2

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

1 December 2017

1 reference

1 December 2017

volume

360

1 reference

1 December 2017

issue

9346

1 reference

1 December 2017

page(s)

1618-1619

1 reference

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911650-3

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911650-3

7 January 2021

The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911650-3

7 January 2021

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911650-3

7 January 2021

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911650-3

7 January 2021

Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911650-3

7 January 2021

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911650-3

7 January 2021

Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911650-3

7 January 2021

The design of a prospective study of pravastatin in the elderly at risk (PROSPER)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911650-3

7 January 2021

Statins and the risk of dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911650-3

7 January 2021

Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens. Cholesterol Treatment Trialists' (CTT) Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911650-3

7 January 2021

Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling Project

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911650-3

7 January 2021

10.1016/S0140-6736(02)11650-3

Identifiers

DOI

1 reference

1 December 2017

1 reference